Unraveling Vitiligo: From Immune Mechanisms to Promising Therapeutic Strategies by Artur Kovenskiy, Nurlubek Katkenov, Zhussipbek Mukatayev, Almagul Kushugulova

Subjects: Get full text

Efficacy and Safety of Ruxolitinib Cream in Atopic Dermatitis Based on Previous Medication History by Andrew Blauvelt, Howard Kallender, Daniel Sturm, Qian Li, Haobo Ren, Lawrence F. Eichenfield

Subjects: Get full text

Screening for Janus kinase-2 exon 12 mutations among Janus kinase-2 V617F-negative polycythemia vera suspected Iraqi patients by Mushtaq M. Khazeem, Alaa Fadhil Alwan

Subjects: “…janus kinase 2 exon 12…”
Get full text

Treatment advances in Vitiligo: An Updated Review by Ishrat Binti Ismail, Yasmeen Jabeen Bhat, Mohd Shurjeel ul Islam

Subjects: Get full text

Refractory pityriasis rubra pilaris treated with abrocitinib by Filip Rob

Subjects: Get full text

Atopic Dermatitis Treatments Before and After Initiation of Ruxolitinib Cream: 6-Month Follow-Up Analysis of a US Payer Claims Database by Liu J, Desai K, Teng CC, Sturm D, Stockbower G, Patadia H, Willey V

Subjects: Get full text

Refractory Chronic Hand Eczema Responds to Oral Upadacitinib by Nada Alghamdi, Abdullah AN.Aljalfan, Abdulmajeed S. Alharbi, Omar I.Alrubaish, Serene R.Almuhaidib

Subjects: “…Hand dermatitis, Hand Eczema, Upadacitinib, Janus kinase inhibitor.…”
Get full text

Integrated safety analysis of tofacitinib from Phase 2 and 3 trials of patients with ankylosing spondylitis by Atul Deodhar, Servet Akar, Jeffrey R. Curtis, Bassel El-Zorkany, Marina Magrey, Cunshan Wang, Joseph Wu, Solomon B. Makgoeng, Ivana Vranic, Sujatha Menon, Dona L. Fleishaker, Annette M. Diehl, Lara Fallon, Arne Yndestad, Robert B. M. Landewé

Subjects: “…Janus kinase inhibitors/adverse effects…”
Get full text

Successful treatment of pyoderma gangrenosum complicated by JAK2V617F mutation-positive myelofibrosis with adalimumab and systemic steroid by Kyohei Shibuta, Koremasa Hayama, Katsuhiro Miura, Hideki Fujita

Subjects: Get full text

A Novel Hope for Alopecia Totalis Patients: Case Report by Manal Elsayed, Laila Al Otaibi, Nael Quraishy, Afzalhussein Yusufali

Subjects: “…janus kinase inhibitor…”
Get full text

Increased risk of Pneumocystis jirovecii colonization in rheumatoid arthritis patients on biologics and Janus kinase inhibitor by Ya-Chun Huang, Nan-Yao Lee, Meng-Yu Weng

Subjects: Get full text

Weight gain secondary to the use of oral Janus kinase inhibitors: A systematic review and meta-analysis by Grace Xiong, BHSc, Eric Yu, Martin Heung, Jaehyeong Yang, BSc, Megan Lowe, MPH, Mohannad Abu-Hilal, MD

Subjects: Get full text

Anti-Inflammatory Effects of Cannabigerol In Vitro and In Vivo Are Mediated Through the JAK/STAT/NFκB Signaling Pathway by Ga Hee Jeong, Ki Chan Kim, Ji Hyun Lee

Subjects: Get full text

RETRACTED: Baricitinib protects mice from sepsis-induced cardiac dysfunction and multiple-organ failure by Chiara Verra, Shireen Mohammad, Gustavo Ferreira Alves, Elisa Porchietto, Sina Maren Coldewey, Sina Maren Coldewey, Massimo Collino, Christoph Thiemermann

Subjects: Get full text

Predictive factors for responders to upadacitinib treatment in patients with atopic dermatitis by Teppei Hagino, Mai Yoshida, Risa Hamada, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda

Subjects: Get full text

Two pemphigoid cases with mucous membrane involvement successfully treated with baricitinib by Tamás Malkovics, Orsolya N. Horváth, Miklós Sárdy

Subjects: Get full text

Does Concomitant Use of Methotrexate with JAK Inhibition Confer Benefit for Cardiovascular Outcomes? A Commentary by Peter C. Taylor, Alejandro Balsa, Anne-Barbara Mongey, Mária Filková, Myriam Chebbah, Solenn Le Clanche, Linda A. W. Verhagen, Torsten Witte, Daniela Opris-Belinski, Hubert Marotte, Jérôme Avouac

Subjects: Get full text

Janus kinase inhibitors and biologics for treatment of livedoid vasculopathy: a systematic review by Yu Liu, Tingting Li, Wei Shi

Subjects: Get full text

Early itch relief with upadacitinib predicts later skin clearance in Atopic dermatitis by Teppei Hagino, Mai Yoshida, Risa Hamada, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda

Subjects: Get full text

Long-term effectiveness and safety of upadacitinib for Japanese patients with moderate-to-severe atopic dermatitis: a real-world clinical study by Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda

Subjects: Get full text